189 related articles for article (PubMed ID: 27888297)
1. Elevated RON protein expression in endometriosis and disease-associated ovarian cancers.
Xu P; Ding S; Zhu L; Le F; Huang X; Tian Y; Zhang X
Arch Gynecol Obstet; 2017 Mar; 295(3):631-639. PubMed ID: 27888297
[TBL] [Abstract][Full Text] [Related]
2. Recepteur d'origine nantais contributes to the development of endometriosis via promoting epithelial-mesenchymal transition of a endometrial epithelial cells.
Yu Q; Wang J; Li T; Guo X; Ding S; Che X; Zhu L; Peng Y; Xu X; Zou G; Zhang X
J Cell Mol Med; 2021 Feb; 25(3):1601-1612. PubMed ID: 33410267
[TBL] [Abstract][Full Text] [Related]
3. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis.
Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P
Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219
[TBL] [Abstract][Full Text] [Related]
4. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
Ren F; Wang DB; Li T
Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis.
Ponandai-Srinivasan S; Andersson KL; Nister M; Saare M; Hassan HA; Varghese SJ; Peters M; Salumets A; Gemzell-Danielsson K; Lalitkumar PGL
Hum Reprod; 2018 Oct; 33(10):1924-1938. PubMed ID: 30020448
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane estrogen receptor GPR30 is more frequently expressed in malignant than benign ovarian endometriotic cysts and correlates with MMP-9 expression.
Long L; Cao Y; Tang LD
Int J Gynecol Cancer; 2012 May; 22(4):539-45. PubMed ID: 22495744
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of hMLH1 in the malignant transformation of ovarian endometriosis.
Ren F; Wang D; Jiang Y; Ren F
Arch Gynecol Obstet; 2012 Jan; 285(1):215-21. PubMed ID: 21556900
[TBL] [Abstract][Full Text] [Related]
8. The macrophage stimulating protein/RON system: a potential novel target for prevention and treatment of endometriosis.
Matsuzaki S; Canis M; Pouly JL; Dechelotte P; Okamura K; Mage G
Mol Hum Reprod; 2005 May; 11(5):345-9. PubMed ID: 15764806
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients.
Ferrandina G; Martinelli E; Petrillo M; Prisco MG; Zucconi A; Santaguida S; Zannoni G; Scambia G; Ferlini C
Gynecol Oncol; 2008 Nov; 111(2):237-43. PubMed ID: 18718649
[TBL] [Abstract][Full Text] [Related]
10. Differences in LINE-1 methylation between endometriotic ovarian cyst and endometriosis-associated ovarian cancer.
Senthong A; Kitkumthorn N; Rattanatanyong P; Khemapech N; Triratanachart S; Mutirangura A
Int J Gynecol Cancer; 2014 Jan; 24(1):36-42. PubMed ID: 24304685
[TBL] [Abstract][Full Text] [Related]
11. Eutopic endometrium and peritoneal, ovarian and colorectal endometriotic tissues express a different profile of nectin-1, -3, -4 and nectin-like molecule 2.
Ballester M; Gonin J; Rodenas A; Bernaudin JF; Rouzier R; Coutant C; Daraï E
Hum Reprod; 2012 Nov; 27(11):3179-86. PubMed ID: 22926846
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of the recepteur d'origine nantais (RON) expression in primary high-grade osteosarcoma.
Wang SL; Weng DF; Wei HX; Huang Z; Lin RQ; Shi K; Lin JH
J Orthop Sci; 2021 Nov; 26(6):1100-1106. PubMed ID: 32972820
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of pigment epithelium-derived factor and increased microvascular density in ovarian endometriotic lesions in women with endometriosis.
Huang X; Chen L; Fu G; Xu H; Zhang X
Eur J Obstet Gynecol Reprod Biol; 2012 Nov; 165(1):104-9. PubMed ID: 22819570
[TBL] [Abstract][Full Text] [Related]
14. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
[TBL] [Abstract][Full Text] [Related]
15. Cyst fluid iron-related compounds as useful markers to distinguish malignant transformation from benign endometriotic cysts.
Yoshimoto C; Iwabuchi T; Shigetomi H; Kobayashi H
Cancer Biomark; 2015; 15(4):493-9. PubMed ID: 25835178
[TBL] [Abstract][Full Text] [Related]
16. Effect of Recepteur d'Origine Nantais expression on chemosensitivity and tumor cell behavior in colorectal cancer.
Kim N; Cho SB; Park YL; Park SY; Myung E; Kim SH; Yu HM; Son YA; Myung DS; Lee WS; Joo YE
Oncol Rep; 2016 Jun; 35(6):3331-40. PubMed ID: 27035413
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for endometriotic-cyst associated ovarian cancer: A case controlled study.
Udomsinkul P; Triratanachart S; Oranratanaphan S
Taiwan J Obstet Gynecol; 2020 Mar; 59(2):269-274. PubMed ID: 32127149
[TBL] [Abstract][Full Text] [Related]
18. Induced endometriosis in the baboon (Papio anubis) increases the expression of the proangiogenic factor CYR61 (CCN1) in eutopic and ectopic endometria.
Gashaw I; Hastings JM; Jackson KS; Winterhager E; Fazleabas AT
Biol Reprod; 2006 Jun; 74(6):1060-6. PubMed ID: 16481591
[TBL] [Abstract][Full Text] [Related]
19. Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance.
Steinbuch SC; Lüß AM; Eltrop S; Götte M; Kiesel L
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673891
[TBL] [Abstract][Full Text] [Related]
20. RON alternative splicing regulation in primary ovarian cancer.
Mayer S; Hirschfeld M; Jaeger M; Pies S; Iborra S; Erbes T; Stickeler E
Oncol Rep; 2015 Jul; 34(1):423-30. PubMed ID: 25997828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
